Tumour VEGF/Non Tumour VEGF protein expression ratio as a biomarker for survival in colorectal cancer patients

European Journal of Surgical Oncology

Volumn 37, Issue 6, 2011, Pages 526-531

  Morales Gutierrez C ^a   Abad Barahona, A ^a   Moreno Gonzalez E ^a   Enriquez De Salamanca R ^a   Vegh, I ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Clinicopathologic features; Colorectal cancer; Immunoassay; Overall survival; VEGF

Indexed keywords

BIOLOGICAL MARKER; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; COLORECTAL SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE HOMOGENATE;

AGED; COLON; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79956013147     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.02.005     Document Type: Article

References (28)

1. J. Folkman What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 1990 4 6 (Pubitemid 20020880)
2. F. Bedoya, J.C. Meneu, and M.I. Macías Mutation in CNR1 gene and VEGF expression in esophageal cancer E Tumori 95 2009 68 75
3. K. Inoue, Y. Ozeki, Y. Suganuma, Y. Sugiura, and S. Tanaka Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma: association with angiogenesis and tumor progression Cancer 79 1997 206 213 (Pubitemid 27029883)
4. R. Bendardaf, A. Buhmeida, and M. Hilska VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival Anticancer Res 28 2008 3865 3870
5. Y.J. Li, Y.J. Deng, G. Wen, and X.L. Zhang Evaluation of angiogenesis in the tumorigenesis and progression of breast cancer Zhonghua Wai Ke Za Zhi 47 2009 519 522
6. J.E. Bluff, S.R. Menakuru, and S.S. Cross Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease Br J Cancer 101 2009 666 672
7. I. Gisterek, R. Matkowki, and A. Lacko Serum vascular endothelial growth factors A, C, and D in human breast tumors Pathol Oncol Res 16 2010 337 344
8. P. Mysliwiec, K. Pawlak, A. Kuklinski, and B. Kedra Combined preoperative plasma endoglobin and VEGF-A assessment on colorectal cancer patients Folia Histochem Cytobiol 46 2008 487 492
9. Z.Y. Tang, S.L. Ye, and Y.K. Liu A decade's studies on metastasis of hepathocellular carcinoma J Cancer Res Clin Oncol 130 2004 187 196
10. R.P. Guo, C. Zhong, and M. Shi Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma J Cancer Res Clin Oncol 132 2006 547 555 (Pubitemid 44078523)
11. S.R. Wedge, D.J. Ogilvie, and M. Dukes ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with board-spectrum antitumor efficacy Cancer Res 60 2000 970 975 (Pubitemid 30129533)
12. C.A. Heckman, T. Holopainen, and M. Wirzenius The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis Cancer Res 68 2008 4754 4762
13. R.A. Goodlad, A.J. Ryan, and S.R. Wedge Inhibiting vascular endothelial growth factor receptor-2 signalling reduces tumor burden in the Apc Min/+ mouse model of early intestinal cancer Carcinogenesis 27 2006 2133 2139 (Pubitemid 44530588)
14. H. Hurwitz, L. Fehrenbacher, and W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342 (Pubitemid 38702844)
15. World Health Organization International histological classification of tumours 2nd ed. 1988-Present World Health Organization/ Berlin Springer-Verlag Geneva
16. L.H. Sobin, and Wittekind Ch UICC "TNM classification of malignant tumors" 6th ed 2002 Wiley New York
17. C. Morales-Gutiérrez, I. Vegh, and F. Colina Survival of patients with colorectal carcinoma Cancer 86 1999 1675 1681
18. K.J. Kim, B. Li, and J. Winer Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in vivo Nature 362 1993 841 844 (Pubitemid 23132159)
19. Z. Inti, R. Steele, and C.C. Compton VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy Cancer 104 2005 2517 2521 (Pubitemid 41691576)
20. F.K. Doger, I. Meteoglu, P. Tunyurek, P. Okyay, and H. Cevikel Does the EGFR and VEGF expression predict the prognosis in colon cancer? Eur Surg Res 38 2006 540 544 (Pubitemid 44836993)
21. A.A. Alabi, A. Suppiah, L.A. Madden, J.R. Monson, and J. Greenman Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients Dis Colon Rectum 52 2009 993 999
22. A.A. Alabi, A. Suppiah, L.A. Madden, J.R. Monson, and J. Greenman Preoperative serum levels of serum VEGF-C is associated with distant metastasis in colorectal cancer patients Int J Colorectal Dis 24 2009 269 274
23. F.J. Gonzalez, A.R. Quesada, and I. Sevilla Prognostic value of serum angiogenic activity in colorectal cancer patients J Cell Mol Med 11 2007 120 128 (Pubitemid 46439630)
24. I. Vegh, A. De la Calle Santiuste, and F. Colina Relationship between biomarker expression and allelic alteration in esophageal carcinoma J Gastroenterol Hepathol 22 2007 2303 2309 (Pubitemid 350145591)
25. I. Vegh, J. De-la Cruz, and S. Navarro Colorectal cancer relapse: allelic alterations associated with tumor marker overexpression Oncology 65 2003 146 151 (Pubitemid 37025976)
26. K. Zafirellis, G. Agrogiannis, A. Zachaki, K. Gravani, A. Karameris, and C. Kombouras Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer J Surg Res 147 2008 99 107 (Pubitemid 351626074)
27. J. Tol, M. Koopman, and A. Cats Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer N Engl J Med 360 2009 563 572
28. D.J. Jonker, C.J. O'Callahan, and C.S. Karapetis Cetuximab for the treatment of colorectal cancer N Engl J Med 357 2007 2040 2048 (Pubitemid 350106711)